Close Menu

NEW YORK (GenomeWeb) – Vela Diagnostics announced today that its next-generation sequencing-based Sentosa SQ HIV genotyping assay is now CE-IVD marked for in vitro diagnostic usage.The company plans to use the assay to detect HIV-1 Group M genomic mutations in protease, reverse transcriptase, and integrase regions from plasma in patients with HIV.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.